Annual EBITDA
$233.41 M
+$11.90 M+5.37%
December 31, 2024
Summary
- As of March 14, 2025, HRMY annual EBITDA is $233.41 million, with the most recent change of +$11.90 million (+5.37%) on December 31, 2024.
- During the last 3 years, HRMY annual EBITDA has risen by +$152.95 million (+190.09%).
- HRMY annual EBITDA is now at all-time high.
Performance
HRMY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$66.33 M
-$6.15 M-8.49%
December 31, 2024
Summary
- As of March 14, 2025, HRMY quarterly EBITDA is $66.33 million, with the most recent change of -$6.15 million (-8.49%) on December 31, 2024.
- Over the past year, HRMY quarterly EBITDA has dropped by -$6.15 million (-8.49%).
- HRMY quarterly EBITDA is now -8.49% below its all-time high of $72.49 million, reached on September 30, 2024.
Performance
HRMY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$233.41 M
+$15.72 M+7.22%
December 31, 2024
Summary
- As of March 14, 2025, HRMY TTM EBITDA is $233.41 million, with the most recent change of +$15.72 million (+7.22%) on December 31, 2024.
- Over the past year, HRMY TTM EBITDA has increased by +$15.72 million (+7.22%).
- HRMY TTM EBITDA is now -0.41% below its all-time high of $234.38 million, reached on March 31, 2024.
Performance
HRMY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HRMY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.4% | -8.5% | +7.2% |
| 3 y3 years | +190.1% | -8.5% | +7.2% |
| 5 y5 years | +263.6% | +308.9% | +263.6% |
HRMY EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +190.1% | -8.5% | +268.1% | -0.4% | +190.1% |
| 5 y | 5-year | at high | +263.6% | -8.5% | +308.9% | -0.4% | +263.6% |
| alltime | all time | at high | +263.6% | -8.5% | +205.2% | -0.4% | +263.6% |
Harmony Biosciences Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $233.41 M(+5.4%) | $66.33 M(-8.5%) | $233.41 M(+7.2%) |
| Sep 2024 | - | $72.49 M(+125.5%) | $217.69 M(+3.6%) |
| Jun 2024 | - | $32.15 M(-48.5%) | $210.15 M(-10.3%) |
| Mar 2024 | - | $62.44 M(+23.4%) | $234.38 M(+5.8%) |
| Dec 2023 | $221.51 M(+50.8%) | $50.61 M(-22.1%) | $221.51 M(-2.8%) |
| Sep 2023 | - | $64.95 M(+15.2%) | $227.78 M(+25.9%) |
| Jun 2023 | - | $56.38 M(+13.7%) | $180.85 M(+10.5%) |
| Mar 2023 | - | $49.58 M(-12.8%) | $163.69 M(+11.5%) |
| Dec 2022 | $146.87 M(+82.5%) | $56.88 M(+215.6%) | $146.87 M(+18.8%) |
| Sep 2022 | - | $18.02 M(-54.0%) | $123.63 M(+17.5%) |
| Jun 2022 | - | $39.21 M(+19.7%) | $105.19 M(+11.9%) |
| Mar 2022 | - | $32.75 M(-2.7%) | $94.02 M(+16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $80.46 M(+5218.0%) | $33.65 M(-8091.9%) | $80.46 M(+142.0%) |
| Sep 2021 | - | -$421.00 K(-101.5%) | $33.25 M(-27.7%) |
| Jun 2021 | - | $28.05 M(+46.1%) | $46.02 M(+68.7%) |
| Mar 2021 | - | $19.19 M(-241.4%) | $27.28 M(+7374.8%) |
| Dec 2020 | $1.51 M(-101.1%) | -$13.57 M(-209.9%) | $365.00 K(-102.0%) |
| Sep 2020 | - | $12.35 M(+32.6%) | -$17.81 M(-69.8%) |
| Jun 2020 | - | $9.31 M(-220.5%) | -$58.91 M(-32.6%) |
| Mar 2020 | - | -$7.73 M(-75.7%) | -$87.36 M(-38.8%) |
| Dec 2019 | -$142.69 M(+245.9%) | -$31.75 M(+10.4%) | -$142.69 M(+28.6%) |
| Sep 2019 | - | -$28.75 M(+50.2%) | -$110.94 M(+35.0%) |
| Jun 2019 | - | -$19.14 M(-69.6%) | -$82.19 M(+30.4%) |
| Mar 2019 | - | -$63.05 M | -$63.05 M |
| Dec 2018 | -$41.26 M | - | - |
FAQ
- What is Harmony Biosciences Holdings annual EBITDA?
- What is the all time high annual EBITDA for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual EBITDA year-on-year change?
- What is Harmony Biosciences Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly EBITDA year-on-year change?
- What is Harmony Biosciences Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings TTM EBITDA year-on-year change?
What is Harmony Biosciences Holdings annual EBITDA?
The current annual EBITDA of HRMY is $233.41 M
What is the all time high annual EBITDA for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual EBITDA is $233.41 M
What is Harmony Biosciences Holdings annual EBITDA year-on-year change?
Over the past year, HRMY annual EBITDA has changed by +$11.90 M (+5.37%)
What is Harmony Biosciences Holdings quarterly EBITDA?
The current quarterly EBITDA of HRMY is $66.33 M
What is the all time high quarterly EBITDA for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly EBITDA is $72.49 M
What is Harmony Biosciences Holdings quarterly EBITDA year-on-year change?
Over the past year, HRMY quarterly EBITDA has changed by -$6.15 M (-8.49%)
What is Harmony Biosciences Holdings TTM EBITDA?
The current TTM EBITDA of HRMY is $233.41 M
What is the all time high TTM EBITDA for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high TTM EBITDA is $234.38 M
What is Harmony Biosciences Holdings TTM EBITDA year-on-year change?
Over the past year, HRMY TTM EBITDA has changed by +$15.72 M (+7.22%)